Caricamento...
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
Several immunomodulatory checkpoint inhibitors have been approved for the treatment of patients with advanced melanoma, including ipilimumab, nivolumab and pembrolizumab. Talimogene laherparepvec is the first oncolytic virus to gain regulatory approval in the USA; it is also approved in Europe. Tali...
Salvato in:
| Pubblicato in: | Cancer Immunol Immunother |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Berlin Heidelberg
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995227/ https://ncbi.nlm.nih.gov/pubmed/27372293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-016-1860-3 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|